CRSP news · CRSP stock

Crispr Therapeutics Reports Growing Casgevy Use Ahead of Key Pipeline Data, RBC Says

Yahoo Finance · Nov 3, 2026 · Crispr Therapeutics AG (CRSP)

Crispr Therapeutics (CRSP) is seeing continued growth in the use of its gene-editing treatment Casge

Original at Yahoo Finance

Not investment advice. Headline and summary only, not a full reprint.